Literature DB >> 28383382

Maternal Cardiovascular Mortality in Illinois, 2002-2011.

Joan Briller1, Abigail R Koch, Stacie E Geller.   

Abstract

OBJECTIVE: To describe the demographic characteristics of women in Illinois who died from cardiovascular disease during pregnancy or up until 1 year postpartum, addressing specific etiologies, timing of death, proportion of potentially preventable mortality, and factors associated with preventability.
METHODS: This is a retrospective analysis from the Illinois Department of Public Health Maternal Mortality Review process using International Classification of Diseases, 9th Revision codes that attributed cardiovascular disease as the immediate or underlying cause of maternal death in Illinois from 2002 to 2011. We categorized the etiology of cardiovascular mortality, analyzed demographic factors associated with cardiovascular mortality in comparison with noncardiovascular causes, defined the relationship to pregnancy, and identified factors associated with preventability.
RESULTS: There were 636 deaths in Illinois from 2002 to 2011 of pregnant women or within 1 year postpartum. One hundred forty women (22.2%) died of cardiovascular causes, for a cardiovascular mortality rate of 8.2 (95% confidence interval 6.9-9.6) per 100,000 live births. Women with cardiovascular mortality were likely to be older and die postpartum. The most common etiologies were related to acquired cardiovascular disease (97.1%) as compared with congenital heart disease (2.9%). Cardiomyopathy was the most common etiology (n=39 [27.9%]), followed by stroke (n=32 [22.9%]), hypertensive disorders (n=18 [12.9%]), arrhythmias (n=15 [10.7%]), and coronary disease (n=13 [9.3%]). Nearly 75% of cardiac deaths were related to pregnancy as compared with 35.3% of noncardiac deaths. More than one fourth of cardiac deaths (28.1%) were potentially preventable, attributable primarily to health care provider and patient factors.
CONCLUSION: From 2002 to 2011, more than one fifth of maternal deaths in Illinois were attributed to cardiovascular disease such as cardiomyopathy. More than one fourth of these deaths were potentially preventable. Health care provider and patient factors were identified, which may be modifiable through education and intensive postpartum monitoring, which may diminish mortality. State maternal mortality reviews can identify opportunities for reducing maternal deaths.

Entities:  

Mesh:

Year:  2017        PMID: 28383382     DOI: 10.1097/AOG.0000000000001981

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

1.  Planned vaginal delivery and cardiovascular morbidity in pregnant women with heart disease.

Authors:  Sarah Rae Easter; Caroline E Rouse; Valeria Duarte; Jenna S Hynes; Michael N Singh; Michael J Landzberg; Anne Marie Valente; Katherine E Economy
Journal:  Am J Obstet Gynecol       Date:  2019-07-13       Impact factor: 8.661

2.  Staying Current: Developing Just-in-time Evidence-Based Learning Objectives for a Maternal Cardiac Arrest Simulation Curriculum.

Authors:  Andrea D Shields; Jacqueline Battistelli; Laurie Kavanagh; Lara Ouellette; Brook Thomson; Peter Nielsen
Journal:  Cardiol Cardiovasc Med       Date:  2022-05-23

Review 3.  Challenges and Opportunities in Identifying, Reviewing, and Preventing Maternal Deaths.

Authors:  Amy St Pierre; Julie Zaharatos; David Goodman; William M Callaghan
Journal:  Obstet Gynecol       Date:  2018-01       Impact factor: 7.661

Review 4.  Team-Based Care of Women With Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 1/5.

Authors:  Melinda B Davis; Katherine Arendt; Natalie A Bello; Haywood Brown; Joan Briller; Kelly Epps; Lisa Hollier; Elizabeth Langen; Ki Park; Mary Norine Walsh; Dominique Williams; Malissa Wood; Candice K Silversides; Kathryn J Lindley
Journal:  J Am Coll Cardiol       Date:  2021-04-13       Impact factor: 24.094

5.  Heart rate as an early predictor of severe cardiomyopathy and increased mortality in peripartum cardiomyopathy.

Authors:  Ryan Cooney; John R Scott; Madeline Mahowald; Elizabeth Langen; Garima Sharma; David P Kao; Melinda B Davis
Journal:  Clin Cardiol       Date:  2022-02-07       Impact factor: 2.882

Review 6.  Obstetric Anesthesia and Heart Disease: Practical Clinical Considerations.

Authors:  Marie-Louise Meng; Katherine W Arendt
Journal:  Anesthesiology       Date:  2021-07-01       Impact factor: 8.986

7.  Assessment of increased risk of arrhythmia in advanced age pregnancies.

Authors:  Mehmet Musa Aslan; Adem Atici
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

Review 8.  Contemporary clinical updates on the prevention of future cardiovascular disease in women who experience adverse pregnancy outcomes.

Authors:  Ki Park; Margo B Minissian; Janet Wei; George R Saade; Graeme N Smith
Journal:  Clin Cardiol       Date:  2020-04-17       Impact factor: 3.287

9.  Predictors of maternal and neonatal complications in women with severe valvular heart disease during pregnancy in Tunisia: a retrospective cohort study.

Authors:  Rania Hammami; Mohamed Ali Ibn Hadj; Yosra Mejdoub; Amine Bahloul; Selma Charfeddine; Leila Abid; Samir Kammoun; Abdallah Dammak; Kais Chaabene
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-08       Impact factor: 3.007

Review 10.  Screening for Cardiovascular Disease in Pregnancy: Is There a Need?

Authors:  Melissa E Chambers; Madushka Y De Zoysa; Afshan B Hameed
Journal:  J Cardiovasc Dev Dis       Date:  2022-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.